肠道菌群与卒中后肺炎相关性的研究进展

doi:10.3969/j.issn.1673-5765.2023.08.012

摘要/Abstract

摘要： 近年来，肠道菌群被认为与卒中后肺炎有关，肠道菌群及其代谢产物通过神经-免疫影响卒中后肺炎，靶向调节肠道菌群如粪菌移植、补充益生菌/益生元有望成为控制卒中后肺炎的重要手段。本文从肠道菌群对卒中后肺炎的影响、可能作用机制及肠道菌群调节在卒中后肺炎治疗中的应用效果等方面进行综述，阐述了卒中后感染的一个易被忽视的重要传染源，以期促进卒中后肺炎靶向治疗策略的发展。

文章导读： 本文阐述了被认为是卒中后肺炎易被忽视的重要传染源——肠道菌群，靶向调节肠道菌群有望成为控制卒中后肺炎的新手段。

关键词: 卒中后肺炎; 肠道菌群; 肠道菌群失调; 肠道功能障碍

Abstract: In recent years, gut microbiota is considered to be related to post-stroke pneumonia. gut microbiota and its metabolites affect post-stroke pneumonia through neuroimmunity. Targeted regulation of gut microbiota, such as fecal bacteria transplantation, and supplementation of probiotics/prebiotics are expected to become important means to control post-stroke pneumonia. This paper reviewed the influence of gut microbiota on post-stroke pneumonia, and its possible mechanism, as well as the effect of gut microbiota regulation in the treatment of post-stroke pneumonia, described an important neglected infectious source of post-stroke infection, in order to promote the development of targeted therapy strategies for post-stroke pneumonia.

Key words: Post-stroke pneumonia; Gut microbiota; Intestinal flora dysregulation; Gut dysfunction

隋冉冉, 山要中, 赵兴军, 陈南南, 刘凤荣, 逄锦晶. 肠道菌群与卒中后肺炎相关性的研究进展[J]. 中国卒中杂志, 2023, 18(8): 947-951.

SUI Ranran, SHAN Yaozhong, ZHAO Xingjun, CHEN Nannan, LIU Fengrong, PANG Jinjing. Advances in the Correlation between Gut Microbiota and Post-stroke Pneumonia[J]. Chinese Journal of Stroke, 2023, 18(8): 947-951.

参考文献

[1] WESTENDORP W F，NEDERKOORN P J，VERMEIJ J D，et al. Post-stroke infection：a systematic review and meta-analysis[J/OL]. BMC Neurol，2011，11：110[2022-10-10]. https://doi.org/10.1186/1471-2377-11-110.
[2] WESTENDORP W F，VERMEIJ J D，SMITH C J，et al. Preventive antibiotic therapy in acute stroke patients：a systematic review and meta-analysis of individual patient data of randomized controlled trials[J]. Eur Stroke J，2021，6（4）：385-394.
[3] WONG C H，JENNE C N，LEE W Y，et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke[J]. Science，2011，334（6052）：101-105.
[4] MRACSKO E，LIESZ A，KARCHER S，et al. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke[J/OL]. Brain Behav Immun，2014，41：200-209[2022-10-10]. https://doi.org/10.1016/j. bbi.2014.05.015.
[5] ROTH S，CAO J Y，SINGH V，et al. Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade[J]. Immunity，2021，54（4）：648-659.
[6] STANLEY D，MASON L J，MACKIN K E，et al. Translocation and dissemination of commensal bacteria in post-stroke infection[J]. Nat Med，2016，22（11）：1277-1284.
[7] BENJAMIN E J，VIRANI S S，CALLAWAY C W，et al. Heart disease and stroke statistics-2018 update：a report from the American Heart Association[J/OL]. Circulation，2018，137（12）：e67-e492[2022-10-10]. https://doi.org/10.1161/CIR.0000000000000558.
[8] GRENHAM S，CLARKE G，CRYAN J F，et al. Brain-gut-microbe communication in health and disease[J/OL]. Front Physiol，2011，2：94[2022-10-10]. https://doi.org/10.3389/fphys.2011.00094.
[9] STILLING R M，VAN DE WOUW M，CLARKE G，et al. The neuropharmacology of butyrate：the bread and butter of the microbiota-gut-brain axis?[J/OL]. Neurochem Int，2016，99：110-132[2022-10-10]. https://doi.org/10.1016/j.neuint.2016.06.011.
[10] DALILE B，VAN OUDENHOVE L，VERVLIET B，et al. The role of short-chain fatty acids in microbiota-gut-brain communication[J]. Nat Rev Gastroenterol Hepatol，2019，16（8）：461-478.
[11] TANG W H，WANG Z N，LEVISON B S，et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J]. N Engl J Med，2013，368（17）：1575-1584.
[12] LANGHORNE P，STOTT D J，ROBERTSON L，et al. Medical complications after stroke：a multicenter study[J]. Stroke，2000，31（6）：1223-1229.
[13] BENAKIS C，BREA D，CABALLERO S，et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells[J]. Nat Med，2016，22（5）：516-523.
[14] DÍAZ-MARUGAN L，GALLIZIOLI M，MÁRQUEZ-KISINOUSKY L，et al. Poststroke lung infection by opportunistic commensal bacteria is not mediated by their expansion in the gut microbiota[J]. Stroke，2023，54（7）：1875-1887.
[15] KNIGHTS D，KUCZYNSKI J，CHARLSON E S，et al. Bayesian community-wide culture-independent microbial source tracking[J]. Nat Methods，2011，8（9）：761-763.
[16] MESSIKA J，MAGDOUD F，CLERMONT O，et al. Pathophysiology of escherichia coli ventilator-associated pneumonia：implication of highly virulent extraintestinal pathogenic strains[J]. Intensive Care Med，2012，38（12）：2007-2016.
[17] MARTINEZ R M，HULTEN K G，BUI U，et al. Molecular analysis and clinical significance of lactobacillus spp. recovered from clinical specimens presumptively associated with disease[J]. J Clin Microbiol，2014，52（1）：30-36.
[18] HANG C H，SHI J X，LI J S，et al. Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats[J]. World J Gastroenterol，2003，9（12）：2776-2781.
[19] ULLUWISHEWA D，ANDERSON R C，MCNABB W C，et al. Regulation of tight junction permeability by intestinal bacteria and dietary components[J]. J Nutr，2011，141（5）：769-776.
[20] FURNESS J B. The enteric nervous system and neurogastroenterology[J]. Nat Rev Gastroenterol Hepatol，2012，9（5）：286-294.
[21] ELENKOV I J，WILDER R L，CHROUSOS G P，et al. The sympathetic nerve-an integrative interface between two supersystems：the brain and the immune system[J]. Pharmacol Rev，2000，52（4）：595-638.
[22] PAVLOV V A，WANG H，CZURA C J，et al. The cholinergic anti-inflammatory pathway：a missing link in neuroimmunomodulation[J]. Mol Med，2003，9（5/8）：125-134.
[23] LOPEZ N E，KRZYZANIAK M J，COSTANTINI T W，et al. Vagal nerve stimulation decreases blood-brain barrier disruption after traumatic brain injury[J]. J Trauma Acute Care Surg，2012，72（6）：1562-1566.
[24] HEGYI P，MALÉTH J，WALTERS J R，et al. Guts and gall：bile acids in regulation of intestinal epithelial function in health and disease[J]. Physiol Rev，2018，98（4）：1983-2023.
[25] MARTÍNEZ-LÓPEZ M，IBORRA S，CONDE-GARROSA R，et al. Microbiota sensing by mincle-syk axis in dendritic cells regulates interleukin-17 and -22 production and promotes intestinal barrier integrity[J]. Immunity，2019，50（2）：446-461.
[26] RIDLON J M，ALVES J M，HYLEMON P B，et al. Cirrhosis，bile acids and gut microbiota：unraveling a complex relationship[J]. Gut Microbes，2013，4（5）：382-387.
[27] HAAK B W，LITTMANN E R，CHAUBARD J L，et al. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT[J]. Blood，2018，131（26）：2978-2986.
[28] LEE J R，HUANG J，MAGRUDER M，et al. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients：a pilot study[J/OL]. Transpl Infect Dis，2019，21（6）：e13180[2022-10-10]. https://doi.org/10.1111/tid.13180.
[29] SCHULTHESS J，PANDEY S，CAPITANI M，et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages[J]. Immunity，2019，50（2）：432-445.
[30] CHAKRABORTY K，RAUNDHAL M，CHEN B B，et al. The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia[J/OL]. Nat Commun，2017，8：13944[2022-10-10]. https://doi.org/10.1038/ncomms13944.
[31] CHANG P V，HAO L，OFFERMANNS S，et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition[J]. Proc Natl Acad Sci U S A，2014，111（6）：2247-2252.
[32] BENAKIS C，POON C，LANE D，et al. Distinct commensal bacterial signature in the gut is associated with acute and long-term protection from ischemic stroke[J]. Stroke，2020，51（6）：1844-1854.
[33] AKHOUNDZADEH K，VAKILI A，SHADNOUSH M，et al. Effects of the oral ingestion of probiotics on brain damage in a transient model of focal cerebral ischemia in mice[J]. Iran J Med Sci，2018，43（1）：32-40.
[34] SINGH V，ROTH S，LLOVERA G，et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke[J]. J Neurosci，2016，36（28）：7428-7440.